Cultural Adaptation and Feasibility Evaluation of Metacognitive Training for Patients with Schizophrenia in Pakistan: A Randomized Controlled Trial

How to cite

Abbasi, Parsa Waqar. 2022. "Cultural Adaptation and Feasibility Evaluation of Metacognitive Training for Patients with Schizophrenia in Pakistan: A Randomized Controlled Trial." AEA RCT Registry. AEARCTR-0009510. https://doi.org/10.1257/rct.9510-3.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Parsa Waqar Abbasi*

* Primary investigator

Registry ID
AEARCTR-0009510
DOI
https://doi.org/10.1257/rct.9510-3.0
First registered
Last updated
Status
Completed
Trial dates
2022-06-01 – 2022-12-19
Countries
Pakistan ()
Registry record
http://www.socialscienceregistry.org/trials/9510

Abstract

Schizophrenia is a severe global mental health problem. Previous studies have suggested different psychological interventions to reduce the severity of schizophrenia symptoms in developing countries. In Pakistan, there has been a lack of research to address this issue and to introduce a measure to overcome this gap. This study aimed to develop a unique intervention to improve the severity of symptoms in individuals with schizophrenia in Pakistan. The purpose of this research was to cross-culturally validate the Metacognitive Training for psychosis (MCT), and to evaluate the feasibility and acceptability of delivering MCT to individuals with schizophrenia in Pakistan. This study was a pre-post design, parallel two arm, double blinded, feasibility, randomized controlled trial. Sixty participants (experimental group, n=30; control group, n=30) were recruited from the departments of psychiatry of various hospitals across Rawalpindi and Islamabad from August to November 2022. Four instruments (Positive and Negative Syndrome Scale, Beck Cogntive Insight Scale, World Health Organization Disability Assessment Schedule, World Health Organization Quality of Life scale) were used to assess symptom severity, cognitive insight, disability, and quality of life in individuals with schizophrenia. A two-way factorial ANOVA was used to examine the efficacy of MCT in reducing symptom severity, cognitive insight, disability, and quality of life. The results of this study demonstrated that MCT was effective in reducing symptom severity and cognitive insight in patients with schizophrenia as compared to the treatment as usual. On the other hand, the results also revealed that MCT was not significantly effective in improving quality of life and disability in patients with schizophrenia. This study will help improve schizophrenia treatment in Pakistan and create insight in policy makers so they can incorporate this therapy in various hospitals across the country.

Intervention

Metacognitive Training for Psychosis (MCT) is an intervention program developed by Dr. Steffen Moritz from the University Medical Centre Hamburg-Eppendorf, Germany, and Dr. Todd Woodward from the University of British Columbia, Canada. It is based on the theoretical framework of cognitive behavioral model of schizophrenia but is somewhat different in that it is more focused towards cognitive distortions.
MCT aims to change the cognitive infrastructure of delusional ideation (Moritz et al., 2021). First published in 2005, it has been translated into almost 37 languages (Penney et al., 2022). It comprises of eight core modules that target common cognitive errors and problem solving biases in schizophrenia (with two additional modules on self-esteem and dealing with stigma which are optional and may supplement or replace the core modules). These errors and biases may, either on their own or in combination, lead to the establishment of false beliefs to the point of delusions. The aim of the sessions is to raise participants’ awareness of these distortions and to encourage them to critically reflect on, complement, or change their current range of problem solving skills (Moritz et al., 2021). There have been several MCT trials conducted throughout the world, and a meta-analysis done by Penny et al. (2022) suggested that the intervention should be integrated in treatment guidelines for schizophrenia.

Experimental design

Study design: Pre and Post Follow-up/Baseline design.
Trial design: A Parallel two-arm, Double-blind, feasibility randomized controlled trial

Design details

Randomization method
Randomization is done in office by random number generator.
Randomization unit
Individual
Observations
60 individuals diagnosed with schizophrenia
Arms
60 participants will be divided into 2 groups/arms (1:1 allocation in each arm): Intervention group/arm= 30 students Compensatory/control group/arm= 30 students
Primary outcomes
Severity of psychotic symptoms will be evaluated through Positive and Negative Syndrome Scale (PANSS).
Secondary outcomes
Quality of Life: WHO Quality of Life scale (WHOQOL-BREF) Functioning: WHO Disability Assessment Scale (WHODAS 2.0) Cognitive Insight: Beck Cognitive Insight Scale (BCIS)

Cited by

No citation data available for this registration yet.

Keywords